NorthCrest Asset Manangement’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
CIM
CGH
CNB
AP
COPPSERS
OIAM
NorthCrest Asset Manangement's GILD Position: Q2 2026 in Review
NorthCrest Asset Manangement increased its Gilead Sciences (GILD) stake by 6.4% in Q2 2026, buying an estimated $771K and bringing the position to 97,027 shares worth $13.1M. The position accounts for 0.34% of the portfolio, ranked #73.
NorthCrest Asset Manangement first reported a position in GILD in Q4 2021 and has held it in 19 quarters since. The position peaked at $14.5M in Q4 2025. 353 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- NorthCrest Asset Manangement held 97,027 shares of Gilead Sciences worth $13.1M as of Q2 2026.
- NorthCrest Asset Manangement bought 5,855 Gilead Sciences shares in Q2 2026, an estimated $771K.
- Gilead Sciences made up 0.34% of NorthCrest Asset Manangement's portfolio in Q2 2026, its #73 holding.
- NorthCrest Asset Manangement first reported a position in Gilead Sciences in Q4 2021 and has held it in 19 quarters since.
- NorthCrest Asset Manangement's Gilead Sciences position peaked at $14.5M in Q4 2025.
- 353 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on NorthCrest Asset Manangement's 13F filing for Q2 2026, filed 15 Jul 2026.